This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Maternal-Fetal Newborn Immunity - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Tobias R. Kollmann, Sing Sing Way, Sabra L. Klein and Arnaud Marchant
Date: October 28 - 29, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Supported by the Directors' Fund
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Summary of Meeting:
Worldwide, deaths from adverse pregnancy outcomes of preterm birth (PTB) and stillbirth (SB) represent the longest, deadliest pandemic in human history. Neonatal infection (e.g. sepsis) is the main cause of death for children under 5 years; with premature babies being especially susceptible to infection. While the final common pathway for SB, PTB and neonatal sepsis is associated with aberrant inflammation in the maternal-fetal dyad, lack of insight into the underlying mechanisms has hampered identification of effective upstream preventative or downstream therapeutic interventions. A focus on immune regulation during pregnancy and in early life is thus urgently warranted. This interdisciplinary Keystone Conference on maternal-fetal-newborn immunity brings together the world’s experts across maternal, fetal and neonatal/infant immunity for the first time with the following goals: 1. Identify the most important gaps in knowledge as well as experimental and analytical technology to answer the question: What is the problem? What is needed to tackle it? 2. Craft the conceptual framework around the immunology of the maternal-fetal-newborn dyad to answer: How does the problem/s and possible solutions fit into the broader areas of immune -tolerance, -resilience, -resistance? How will the work proposed shift current paradigms? 3. Initiate a global consortium to tackle adverse pregnancy outcomes on the necessary global scale. This is to answer: What does it take to recognize the maternal-fetal-newborn unit as one biological unit? What does it take to make this a global priority?
We gratefully acknowledge additional support for this conference from:
Science Immunology / AAAS
Keystone Symposia thanks the following Contributors.
Science Immunology / AAAS
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1 R13 AI152254-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found